Acute kidney injury in sepsis

Intensive Care Medicine

Volumn 43, Issue 6, 2017, Pages 816-828

  Bellomo, Rinaldo ^a,b   Kellum, John A ^c   Ronco, Claudio ^d   Wald, Ron ^e,f   Martensson, Johan ^g   Maiden, Matthew ^h,i   Bagshaw, Sean M ^j   Glassford, Neil J ^b,k   Lankadeva, Yugeesh ^l   Vaara, Suvi T ^m   Schneider, Antoine ⁿ  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b AUSTIN HOSPITAL   (Australia)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d SAN BORTOLO HOSPITAL   (Italy)

^e ST MICHAEL'S HOSPITAL   (Canada)

^f ST MICHAEL'S HOSPITAL   (Canada)

^g KAROLINSKA INSTITUTE   (Sweden)

^h UNIVERSITY HOSPITAL GEELONG   (Australia)

ⁱ ROYAL ADELAIDE HOSPITAL   (Australia)

^j UNIVERSITY OF ALBERTA   (Canada)

^k MONASH UNIVERSITY   (Australia)

^l FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^m HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

ⁿ LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

more..

Author keywords

Acute kidney injury; Biomarkers; Creatinine; Recovery; Renal replacement therapy; Sepsis

Indexed keywords

ANTIBIOTIC AGENT; BIOLOGICAL MARKER; VASOACTIVE AGENT; CREATININE;

ACUTE KIDNEY FAILURE; ANTIBIOTIC THERAPY; CLINICAL TRIAL (TOPIC); FLUID THERAPY; HEMODYNAMICS; HISTOPATHOLOGY; HUMAN; MORTALITY; NONHUMAN; PATHOGENESIS; PROGNOSIS; RENAL REPLACEMENT THERAPY; REVIEW; SEPSIS; BLOOD; COMPLICATION; INTENSIVE CARE; INTENSIVE CARE UNIT; KIDNEY; KIDNEY FUNCTION TEST; PATHOPHYSIOLOGY; PROCEDURES;

ACUTE KIDNEY INJURY; BIOMARKERS; CREATININE; CRITICAL CARE; HUMANS; INTENSIVE CARE UNITS; KIDNEY; KIDNEY FUNCTION TESTS; RENAL REPLACEMENT THERAPY; SEPSIS;

EID: 85016643780     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-017-4755-7     Document Type: Review

References (89)

1. KDIGO AKI Writing Group (2012) Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline for acute kidney injury. Kidney Int 2(Suppl. 2):1–141
2. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Acute Dialysis Quality Initiative Workgroup (2004) Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the acute dialysis quality initiative (ADQI) Group. Crit Care 8:R204–R212
3. Singer M, Deutschman CS, Seymour CW et al (2016) The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315:801–810
4. Kellum JA, Bellomo R, Ronco C (2016) Does this patient have acute kidney injury? An AKI checklist. Intensive Care Med 42:96–99
5. Bagshaw SM, Bennett M, Devarajan P, Bellomo R (2013) Urine biochemistry in septic and non-septic acute kidney injury: a prospective observational study. J Crit Care 28:371–378
6. Kellum JA, Sileanu FE, Murugan R, Lucko N, Shaw AD, Clermont G (2015) Classifying AKI by urine output versus serum creatinine level. J Am Soc Nephrol 26:2231–2238
7. McCullough PA, Sahw AD, Haase M et al (2013) Diagnosis of acute kidney injury using funcitonal and injury biomarkers: workgroup statements from the tenth acute dialysis quality initiative consensus conference. Contrib Nephrol 182:13–29
8. Mårtensson J, Bellomo R (2014) The rise and fall of NGAL in acute kidney injury. Blood Purif 37:304–310
9. Mårtensson J, Xu S, Bell M, Martling CR, Venge P (2012) Immunoassays distinguishing between HNL/NGAL released in urine from kidney epithelial cells and neutrophils. Clin Chim Acta 413:1661–1667
10. Haase M, Devarajan P, Haase-Fielitz A, Bellomo R, Cruz DN, Wagener G, Krawczeski CD, Koyner JL, Murray P, Zappitelli M, Goldstein SL, Makris K, Ronco C, Mårtensson J, Martling CR, Venge P, Siew E, Ware LB, Ikizler A, Mertens PR (2011) The outcome of neutrophil gelatinase-associated lipocalin-positive subclinical acute kidney injury. J Am Coll Cardiol 57:1752–1761
11. Nickolas TL, Schmidt-Ott KM, Canetta P, Forster C, Singer E, Sise M, Elger A, Maarouf O, Sola-Del Valle DA, O’Rourke M, Sherman E, Lee P, Geara A, Imus P, Guddati A, Polland A, Rahman W, Elitok S, Malik N, Giglio J, El-Sayegh S, Devarajan P, Hebbar S, Saggi SJ, Hahn B, Kettritz R, Luft FC, Barasch J (2012) Diagnostic and prognostic stratification in the emergency department using urinary biomarkers of nephron damage. J Am Coll Cardiol 59:246–255
12. Kashani K, Al-Khafaji A, Ardiles T, Artigas A, Bagshaw SM, Bell M, Bihorac A, Birkhahn R, Cely CM, Chawla LS, Davison DL, Feldkamp T, Forni LG, Gong MN, Gunnerson KJ, Haase M, Hackett J, Honore PM, Hoste EA, Joannes-Boyau O, Joannidis M, Kim P, Koyner JL, Laskowitz DT, Lissauer ME, Marx G, McCullough PA, Mullaney S, Ostermann M, Rimmele T, Shapiro NI, Shaw AD, Shi J, Sprague AM, Vincent J-L, Vinsonneau C, Wagner L, Walker MG, Wilkerson RG, Zacharowski K, Kellum JA (2013) Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 17:R25
13. Gomez H, Kellum JA (2016) Sepsis-induced acute kidney injury. Curr Opin Crit Care 22:546–553
14. Ronco C, Chawla LS (2016) Glomerular and tubular kidney stress test: new tools for a deeper evaluation of kidney function. Nephron 134:191–194
15. Wang E, Meier DJ, Sandoval RM, Von Hendy-Willson VE, Pressler BM, Bunch RM, Alloosh M, Sturek MS, Schwartz GJ, Molitoris BA (2012) A portable fiberoptic ratiometric fluorescence analyzer provides rapid point-of-care determination of glomerular filtration rate in large animals. Kidney Int 81:112–117
16. Bagshaw SM, Uchino S, Bellomo R et al (2007) Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes. Clin J Am Soc Nephrol 2:431–439
17. Bouchard J, Acharya A, Cerda J et al (2015) A prospective international multicenter study of AKI in the intensive care unit. Clin J Am Soc Nephrol 10:1324–1331
18. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR (2001) Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med 29:1303–1310
19. Vincent JL, Sakr Y, Sprung CL et al (2006) Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 34:344–353
20. Poukkanen M, Vaara ST, Pettila V et al (2013) Acute kidney injury in patients with severe sepsis in Finnish intensive care units. Acta Anaesthesiol Scand 57:863–872
21. Gordon AC, Mason AJ, Thirunavukkarasu N et al (2016) Effect of early vasopressin vs norepinephrine on kidney failure in patients with septic shock: the VANISH randomized clinical trial. JAMA 316:509–518
22. Haase-Fielitz Al, Haase M, Bellomo R, Dragun D (2007) Genetic polymorphisms in sepsis- and cardiopulmonary bypass-associated acute kidney injury. Contrib Nephrol 156:75–91
23. Zhao B, Lu Q, Cheng Y, Belcher JM et al (2017) A genome-wide association study to identify single nucleotide polymorphisms for acute kidney injury. Am J Respir Crit Care Med 195:482–490
24. Kaukonen KM, Bailey M, Suzuki S, Pilcher D, Bellomo R (2014) Mortality related to severe sepsis and septic shock among critically ill patients in Australia and New Zealand, 2000–2012. JAMA 311:1308–1316
25. Wald R, McArthur E, Adhikari NK et al (2015) Changing incidence and outcomes following dialysis-requiring acute kidney injury among critically ill adults: a population-based cohort study. Am J Kidney Dis 65:870–877
26. Schrier RW, Wang W (2004) Acute renal failure and sepsis. N Engl J Med 351:159–169
27. Langenberg C, Wan L, Egi M et al (2006) Renal blood flow in experimental septic acute renal failure. Kidney Int 69:1996–2002
28. Di Giantomasso D, May CN, Bellomo R (2003) Vital organ blood flow during hyperdynamic sepsis. Chest 124:1053–1059
29. Langenberg C, Bellomo R, May C, Wan L, Egi M, Morgera S (2005) Renal blood flow in sepsis. Crit Care 9:R363–R374
30. Prowle JR, Molan MP, Henessy E, Bellomo R (2012) Measurement of renal blood flow by phase contrast magnetic resonance imaging during septic acute kidney injury: a pilot investigation. Crit Care Med 40:1768–1776
31. Verma SK, Molitoris BA (2015) Renal endothelial injury and microvascular dysfunction in acute kidney injury. Semin Nephrol 35:96–107
32. Post EH, Kellum JA, Bellomo R, Vincent J-L (2017) Renal perfusion in sepsis: from macro- to microcirculation. Kidney Int 91:45–60
33. Calzavacca P, Evans RG, Bailey M, Bellomo R, May CN (2015) Cortical and medullary tissue perfusion and oxygenation in experimental septic acute kidney injury. Crit Care Med 43:e431–e439
34. Lankadeva YR, Kosaka J, Evans RG, Bailey M, Bellomo R, May CN (2016) Intra-renal and urinary oxygenation during norepinephrine resuscitation in ovine septic acute kidney injury. Kidney Int 90:100–108
35. Casellas D, Mimran A (1979) Aglomerular pathways in intrarenal microvasculature of aged rats. Am J Anat 156:293–299
36. Dellepiane S, Marengo M, Cantaluppi V (2016) Detrimental cross-talk between sepsis and acute kidney injury: new pathogenic mechanisms, early biomarkers and targeted therapies. Crit Care 20:61
37. Mariano F, Cantaluppi V, Stella M et al (2008) Circulating plasma factors induce tubular and glomerular alterations in septic burns patients. Crit Care 12:R42
38. Doi K, Leelahavanichkul A, Yuen PST et al (2009) Animal models of sepsis and sepsis-induced kidney injury. J Clin Investig 119:2868–2878
39. Lerolle N, Nochy D, Guérot E et al (2010) Histopathology of septic shock induced acute kidney injury: apoptosis and leukocytic infiltration. Intensive Care Med 36:471–478
40. Takasu O, Gaut JP, Watanabe E et al (2013) Mechanisms of cardiac and renal dysfunction in patients dying of sepsis. Am J Resp Crit Care Med 187:509–517
41. Langenberg C, Gobe G, Hood S et al (2014) Renal histopathology during experimental septic acute kidney injury and recovery. Crit Care Med 42:e58–e67
42. Maiden MJ, Otto S, Brealey JK et al (2016) Structure and function of the kidney in septic shock. A prospective controlled experimental study. Am J Resp Crit Care Med 194:692–700
43. Basu RK, Zappitelli M, Brunner L, Wang Y, Wong HR, Chawla LS et al (2014) Derivation and validation of the renal angina index to improve the prediction of acute kidney injury in critically ill children. Kidney Int 85(3):659–667
44. Honore PM, Nguyen HB, Gong M, Chawla LS, Bagshaw SM, Artigas A et al (2016) Urinary tissue inhibitor of metalloproteinase-2 and insulin-like growth factor-binding protein 7 for risk stratification of acute kidney injury in patients with sepsis. Crit Care Med 44(10):1851–1860
45. Colpaert K, Hoste EA, Steurbaut K, Benoit D, Van Hoecke S, De Turck F et al (2012) Impact of real-time electronic alerting of acute kidney injury on therapeutic intervention and progression of RIFLE class. Crit Care Med 40(4):1164–1170
46. Bagshaw SM, Goldstein SL, Ronco C, Kellum JA, Group AC (2016) Acute kidney injury in the era of big data: the 15(th) Consensus Conference of the Acute Dialysis Quality Initiative (ADQI). Can J Kidney Health Dis 3:5
47. Lachance P, Villeneuve P, Wilson FP, Selby FM, Featherstone RM et al (2016) Impact of e-alert for detection of acute kidney injury on processes of care and outcomes: protocol for a systematic review and meta-analysis. BMJ Open 5:e011152
48. Goldstein SL, Mottes T, Simpson K, Barclay C, Muething S, Haslam DB et al (2016) A sustained quality improvement program reduces nephrotoxic medication-associated acute kidney injury. Kidney Int 90:212–221
49. Bagshaw SM, Lapinsky S, Dial S, Arabi Y, Dodek P, Wood G et al (2009) Acute kidney injury in septic shock: clinical outcomes and impact of duration of hypotension prior to initiation of antimicrobial therapy. Intensive Care Med 35:871–881
50. Kellum JA, Chawla LS, Keener C, Singbartl K, Palevsky PM, Pike FL et al (2016) The effects of alternative resuscitation strategies on acute kidney injury in patients with septic shock. Am J Respir Crit Care Med 193:281–287
51. Mouncey PR, Osborn TM, Power GS, Harrison DA, Sadique MZ, Grieve RD, Jahan R, Harvey SE, Bell D, Bion JF, Coats TJ, Singer M, Young JD, Rowan KM (2015) Trial of early, goal-directed resuscitation for septic shock. N Engl J Med 372:1301–1311
52. The ProCess Investigators (2014) A randomized trial of protocol-based care for early septic shock. N Engl J Med 370:1683–1693
53. Peake SL, Delaney A, Bailey M, Bellomo R, Cameron PA, Cooper DJ, Higgins AM, Holdgate A, Howe BD, Webb SA, Williams P (2014) Goal-directed resuscitation for patients with early septic shock. N Engl J Med 371:1496–1506
54. Gordon AC, Russell JA, Walley KR, Singer J, Ayers D, Storms MM et al (2016) The effects of vasopressin on acute kidney injury in septic shock. Intensive Care Med 36:83–91
55. Morelli A, Ricci Z, Bellomo R, Ronco C, Rocco M, Conti G et al (2005) Prophylactic fenoldopam for renal protection in sepsis: a randomized, double-blind, placebo-controlled pilot trial. Crit Care Med 33:2451–2456
56. Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lee J, Lo S, McArthur C, McGuiness S, Norton R, Myburgh J, Scheinkestel C, Su S (2012) An observational study fluid balance and patient outcomes in the randomized evaluation of normal vs. augmented level of replacement therapy trial. Crit Care Med 40:1753–1760
57. Boyd JH, Forbes J, Nakada TA, Walley KR, Russell JA (2011) Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med 39:259–265
58. Wiedemann HP, Wheeler AP, Bernard GR, Thompson BT, Hayden D, deBoisblanc B, Connors AF Jr, Hite RD, Harabin AL (2006) Comparison of two fluid-management strategies in acute lung injury. N Engl J Med 354:2564–2575
59. Bouchard J, Soroko SB, Chertow GM, Himmelfarb J, Ikizler TA, Paganini EP, Mehta RL (2009) Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int 76:422–427
60. Hjortrup PB, Haase N, Bundgaard H, Thomsen SL, Winding R, Pettila V, Aaen A, Lodahl D, Berthelsen RE, Christensen H, Madsen MB, Winkel P, Wetterslev J, Perner A, CLASSIC Trial Group, Scandinavian Critical Care Trials Group (2016) Restricting volumes of resuscitation fluid in adults with septic shock after initial management: the CLASSIC randomised, parallel-group, multicentre feasibility trial. Intensive Care Med 42:1695–1705
61. Lipscey M, Craig J, Suibiakto I et al (2015) Primary fluid bolus therapy for infection-associated hypotension in the emergency department. Crit Care Resusc 17:6–11
62. Lipscey M, Suibiakto I, Chiong J et al (2016) Secondary fluid bolus therapy for infection-associated hypotension. Crit Care Resusc 18:165–173
63. Bannard-Smith J, Alexander P, Glassford N et al (2015) Haemodynamic and biochemcial responses to fluid bolus therapy with human albumin solution, 4% versus 20% in critically ill adults. Crit Care Resusc 17:122–128
64. Yunos NM, Bellomo R, Glassford N, Sutcliffe H, Lam Q, Bailey M (2015) Chloride-liberal vs. chloride-restrictive intravenous fluid administration and acute kidney injury: an extended analysis. Intensive Care Med 41:257–264
65. Shaw AD, Raghunathan K, Peyerl FW, Munson SH, Paluszkiewicz SM, Schermer CR (2014) Association between intravenous chloride load during resuscitation and in-hospital mortality among patients with SIRS. Intensive Care Med 40:1897–1905
66. Young P, Bailey M, Beasley R, Henderson S, Mackle D, McArthur C, McGuinness S, Mehrtens J, Myburgh J, Psirides A, Reddy S, Bellomo R, SPLIT Investigators, Anzics CTG (2015) Effect of a buffered crystalloid solution vs saline on acute kidney injury among patients in the intensive care unit: the SPLIT randomized clinical trial. JAMA 314:1701–1710
67. Semler MW, Wanderer JP, Ehrenfeld JM, Stollings JL, Self WH, Siew ED, Wang L, Byrne DW, Shaw AD, Bernard GR, Rice TW, SALT Investigators and the Pragmatic Critical Care Research Group (2016) Balanced crystalloids versus saline in the intensive care unit: the SALT randomized Trial. Am J Resp Crit Care Med. doi:10.1164/rccm.201607-1345OC
68. Finfer S, Bellomo R, Boyce N, French J, Myburgh J, Norton R et al (2004) A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl Med 350:2247–2256
69. Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Aneman A, Madsen KR, Moller MH, Elkjaer JM, Poulsen LM, Bendtsen A, Winding R, Steensen M, Berezowicz P, Soe-Jensen P, Bestle M, Strand K, Wiis J, White JO, Thornberg KJ, Quist L, Nielsen J, Andersen LH, Holst LB, Thormar K, Kjaeldgaard AL, Fabritius ML, Mondrup F, Pott FC, Moller TP, Winkel P, Wetterslev J, 6S Trial Group, Scandinavian Critical Care Trials Group (2012) Hydroxyethyl starch 130/0.42 versus Ringer’s acetate in severe sepsis. N Engl J Med 367:124–134
70. Pisano A, Landoni G, Bellomo R (2016) The risk of infusing gelatin? Die-hard misconceptions and forgotten (or ignored) truths. Miner Anestesiol 82:1107–1114
71. Chawla LS, Busse L, Brasha-Mitchell E, Davison D, Honiq J, Alotaibi Z, Seneff MG (2014) Intravenous angiotensin II for the treatment of high-output shock (ATHOS trial): a pilot study. Crit Care 18:534
72. Myburgh JA, Higgins A, Jovanovska A, Lipman J, Ramakrishnan N, Santamaria J (2008) A comparison of epinephrine and norepinephrine in critically ill patients. Intensive Care Med 34:2226–2234
73. De Backer D, Aldecoa C, Njimi H, Vincent J-L (2012) Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis. Crit Care Med 40:725–730
74. Asfar P, Meziani F, Hamel JE et al (2014) High versus low blood pressure target in patients with septic shock. N Engl J Med 370:1583–1593
75. Payen D, Mateo J, Cavaillon JM, Fraisse F, Floriot C, Vicaut E (2009) Impact of continuous venovenous hemofiltration on organ failure during the early phase of severe sepsis: a randomized controlled trial. Crit Care Med 37:803–810
76. Zhang P, Yang Y, Lv R, Zhang Y, Xie W, Chen J (2012) Effect of the intensity of continuous renal replacement therapy in patients with sepsis and acute kidney injury: a single-center randomized clinical trial. Nephrol Dial Transpl 27:967–973
77. Joannes-Boyau O, Honore PM, Perez P, Bagshaw SM, Grand H, Canivet JL, Dewitte A, Flamens C, Pujol W, Grandoulier AS et al (2013) High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicentre randomized controlled trial. Intensive Care Med 39:1535–1546
78. Park JT, Lee H, Kee YK, Park S, Oh HJ, Han SH, Joo KW, Lim CS, Kim YS, Kang SW et al (2016) High-dose versus conventional-dose continuous venovenous hemodiafiltration and patient and kidney survival and cytokine removal in sepsis-associated acute kidney injury: a randomized controlled trial. Am J Kidney Dis 68:599–608
79. Zarbock A, Kellum JA, Schmidt C, Van Aken H, Wempe C, Pavenstadt H, Boanta A, Gerss J, Meersch M (2016) Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN randomized clinical trial. JAMA 315:2190–2199
80. Gaudry S, Hajage D, Schortgen F, Martin-Lefevre L, Pons B, Boulet E, Boyer A, Chevrel G, Lerolle N, Carpentier D et al (2016) Initiation strategies for renal-replacement therapy in the intensive care unit. N Engl J Med 375:122–133
81. RENAL Replacement Therapy Study Investigators, Bellomo R, Cass A, Cole L, Finfer S, Gallagher M, Lo S, McArthur C, McGuinness S, Myburgh J et al (2009) Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 361:1627–1638
82. Palevsky PM, Zhang JH, O’Connor TZ, Chertow GM, Crowley ST, Choudhury D, Finkel K, Kellum JA, Paganini E, Schein RM et al (2008) Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 359:7–20
83. Roberts DM, Liu X, Roberts JA, Nair P, Cole L, Roberts MS, Lipman J, Bellomo R (2015) A multicenter study on the effect of continuous hemodiafiltration intensity on antibiotic pharmacokinetics. Crit Care 13(19):84
84. Caironi P, Tognoni G, Masson S et al (2014) Albumin replacement in patients with severe sepsis or septic shock. N Engl J Med 370:1412–1421
85. Peters E, Mehta RL, Murray PT, Hummel J, Joannidis M, Kellum JA, Arend J, Pikkers P (2016) Study protocol for a multicentre randomised controlled trial: safety, tolerability, efficacy, and quality of life of a human recombinant alkaline phosphatase in patients with sepsis-associated acute kidney injury. BMJ Open 6:e012371
86. Chawla LS, Russell JA, Bagshaw SM et al (2017) Angiotensin for the treatment of high output shock 3 (ATHOS-3): a study protocol for a phase 3, double-blind, randomized controlled trial. Crit Care Resusc 2017 19:43–49.
87. Venot M, Weis L, Clec’h C, Darmon M, Allaouchiche B, Goldgran-Toledano D, Garrouste-Orgeas M, Adrie C, Timsit JF, Azoulay E (2015) Acute kidney injury in severe sepsis and septic shock in patients with and without diabetes mellitus: a multicenter study. PLoS One 10:e0127411
88. Wald R, Quinn RR, Adhikari NK et al (2012) Risk of chronic dialysis and death following acute kidney injury. Am J Med 125:585–593
89. Pickkers P, Ostermann M, Joannidis M, Zarbock A, Hoste E, Bellomo R, Prowle J, Darmon M, Bonventre JV, Forni L, Bagshaw SM, Schetz M (2017) The intensive care medicine agenda on acute kidney injury. Intensive Care Med. doi:10.1007/s00134-017-4687-2